1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Rawla P and Barsouk A: Epidemiology of
gastric cancer: Global trends, risk factors and prevention. Prz
Gastroenterol. 14:26–38. 2019.PubMed/NCBI
|
3
|
Thrift AP and El-Serag HB: Burden of
gastric cancer. Clin Gastroenterol Hepatol. 18:534–542. 2020.
View Article : Google Scholar
|
4
|
Shen L, Li J, Xu J, Pan H, Dai G, Qin S,
Wang L, Wang J, Yang Z, Shu Y, et al: Bevacizumab plus capecitabine
and cisplatin in Chinese patients with inoperable locally advanced
or metastatic gastric or gastroesophageal junction cancer:
Randomized, double-blind, phase III study (AVATAR study). Gastric
Cancer. 18:168–176. 2015. View Article : Google Scholar :
|
5
|
Lordick F, Kang YK, Chung HC, Salman P, Oh
SC, Bodoky G, Kurteva G, Volovat C, Moiseyenko VM, Gorbunova V, et
al: Capecitabine and cisplatin with or without cetuximab for
patients with previously untreated advanced gastric cancer
(EXPAND): A randomised, open-label phase 3 trial. Lancet Oncol.
14:490–499. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Thuss-Patience PC, Shah MA, Ohtsu A, Van
Cutsem E, Ajani JA, Castro H, Mansoor W, Chung HC, Bodoky G,
Shitara K, et al: Trastuzumab emtansine versus taxane use for
previously treated HER2-positive locally advanced or metastatic
gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): An
international randomised, open-label, adaptive, phase 2/3 study.
Lancet Oncol. 18:640–653. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Saha N, Robev D, Himanen JP and Nikolov
DB: ADAM proteases: Emerging role and targeting of the
non-catalytic domains. Cancer Lett. 467:50–57. 2019. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kveiborg M, Albrechtsen R, Couchman JR and
Wewer UM: Cellular roles of ADAM12 in health and disease. Int J
Biochem Cell Biol. 40:1685–1702. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Huang X and Xie X, Liu P, Yang L, Chen B,
Song C, Tang H and Xie X: Adam12 and lnc015192 act as ceRNAs in
breast cancer by regulating miR-34a. Oncogene. 37:6316–6326. 2018.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Luo ML, Zhou Z, Sun L, Yu L, Sun L, Liu J,
Yang Z, Ran Y, Yao Y and Hu H: An ADAM12 and FAK positive feedback
loop amplifies the interaction signal of tumor cells with
extracellular matrix to promote esophageal cancer metastasis.
Cancer Lett. 422:118–128. 2018. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang X, Wang Y, Gu J, Zhou D, He Z, Wang X
and Ferrone S: ADAM12-L confers acquired 5-fluorouracil resistance
in breast cancer cells. Sci Rep. 7:96872017. View Article : Google Scholar : PubMed/NCBI
|
12
|
Duhachek-Muggy S, Qi Y, Wise R, Alyahya L,
Li H, Hodge J and Zolkiewska A: Metalloprotease-disintegrin ADAM12
actively promotes the stem cell-like phenotype in claudin-low
breast cancer. Mol Cancer. 16:322017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhu H, Wang G, Zhu H and Xu A: ITGA5 is a
prognostic biomarker and correlated with immune infiltration in
gastrointestinal tumors. BMC Cancer. 21:2692021. View Article : Google Scholar : PubMed/NCBI
|
14
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wang Q, Wen YG, Li DP, Xia J, Zhou CZ, Yan
DW, Tang HM and Peng ZH: Upregulated INHBA expression is associated
with poor survival in gastric cancer. Med Oncol. 29:77–83. 2012.
View Article : Google Scholar
|
16
|
Modhukur V, Iljasenko T, Metsalu T, Lokk
K, Laisk-Podar T and Vilo J: MethSurv: A web tool to perform
multivariable survival analysis using DNA methylation data.
Epigenomics. 10:277–288. 2018. View Article : Google Scholar
|
17
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2017. View Article : Google Scholar
|
18
|
Zhou KR, Liu S, Cai L and Bin L: The
Encyclopedia of RNA Interactomes (ENCORI): The Encyclopedia of RNA
Interactomes, 2021.
|
19
|
Kertesz M, Iovino N, Unnerstall U, Gaul U
and Segal E: The role of site accessibility in microRNA target
recognition. Nat Genet. 39:1278–1284. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Betel D, Koppal A, Agius P, Sander C and
Leslie C: Comprehensive modeling of microRNA targets predicts
functional non-conserved and non-canonical sites. Genome Biol.
11:R902010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Grimson A, Farh KK, Johnston WK,
Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: Determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chang L, Zhou G, Soufan O and Xia J:
miRNet 2.0: Network-based visual analytics for miRNA functional
analysis and systems biology. Nucleic Acids Res. 48:W244–W251.
2020. View Article : Google Scholar : PubMed/NCBI
|
23
|
Vasaikar SV, Straub P, Wang J and Zhang B:
LinkedOmics: Analyzing multi-omics data within and across 32 cancer
types. Nucleic Acids Res. 46:D956–D963. 2018. View Article : Google Scholar :
|
24
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38:W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, Jensen LJ and Mering CV: STRING v11: Protein-protein association
networks with increased coverage, supporting functional discovery
in genome-wide experimental datasets. Nucleic Acids Res.
47:D607–D613. 2019. View Article : Google Scholar
|
26
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu
JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis
of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110. 2017.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
28
|
Remmert M, Biegert A, Hauser A and Söding
J: HHblits: Lightning-fast iterative protein sequence searching by
HMM-HMM alignment. Nature Methods. 9:173–175. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Pearson WR and Lipman DJ: Improved tools
for biological sequence comparison. Proc Natl Acad Sci USA.
85:2444–2448. 1988. View Article : Google Scholar : PubMed/NCBI
|
30
|
Sievers F, Wilm A, Dineen D, Gibson TJ,
Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al:
Fast, scalable generation of high-quality protein multiple sequence
alignments using Clustal Omega. Mol Syst Biol. 7:5392011.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Larkin MA, Blackshields G, Brown NP,
Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm
A, Lopez R, et al: Clustal W and Clustal X version 2.0.
Bioinformatics. 23:2947–2948. 2007. View Article : Google Scholar : PubMed/NCBI
|
32
|
Martí-Renom MA, Stuart AC, Fiser A,
Sánchez R, Melo F and Sali A: Comparative protein structure
modeling of genes and genomes. Annu Rev Biophys Biomol Struct.
29:291–325. 2000. View Article : Google Scholar : PubMed/NCBI
|
33
|
Berman HM, Westbrook J, Feng Z, Gilliland
G, Bhat TN, Weissig H, Shindyalov IN and Bourne PE: The protein
data bank. Nucleic Acids Res. 28:235–242. 2000. View Article : Google Scholar
|
34
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Liu X, Salokas K, Tamene F, Jiu Y,
Weldatsadik RG, Öhman T and Varjosalo M: An AP-MS- and
BioID-compatible MAC-tag enables comprehensive mapping of protein
interactions and subcellular localizations. Nat Commun. 9:11882018.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Suzuki A, Kadota N, Hara T, Nakagami Y,
Izumi T, Takenawa T, Sabe H and Endo T: Meltrin alpha cytoplasmic
domain interacts with SH3 domains of Src and Grb2 and is
phosphorylated by v-Src. Oncogene. 19:5842–5580. 2000. View Article : Google Scholar : PubMed/NCBI
|
37
|
Malinin NL, Wright S, Seubert P, Schenk D
and Griswold-Prenner I: Amyloid-beta neurotoxicity is mediated by
FISH adapter protein and ADAM12 metalloprotease activity. Proc Natl
Acad Sci USA. 102:3058–3063. 2005. View Article : Google Scholar : PubMed/NCBI
|
38
|
Harold D, Jehu L, Turic D, Hollingworth P,
Moore P, Summerhayes P, Moskvina V, Foy C, Archer N, Hamilton BA,
et al: Interaction between the ADAM12 and SH3MD1 genes may confer
susceptibility to late-onset Alzheimer's disease. Am J Med Genet B
Neuropsychiatr Genet. 144B:448–452. 2007. View Article : Google Scholar : PubMed/NCBI
|
39
|
Wang R, Godet I, Yang Y, Salman S, Lu H,
Lyu Y, Zuo Q, Wang Y, Zhu Y, Chen C, et al: Hypoxia-inducible
factor-dependent ADAM12 expression mediates breast cancer invasion
and metastasis. Proc Natl Acad Sci USA. 118:e20204901182021.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Díaz B, Yuen A, Iizuka S, Higashiyama S
and Courtneidge SA: Notch increases the shedding of HB-EGF by
ADAM12 to potentiate invadopodia formation in hypoxia. J Cell Biol.
201:279–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
41
|
Li Y, Tian M, Liu W, Wang D, Zhou Z, Pei
Q, Huang Y, Tan F and Güngör C: Follistatin-Like 3 enhances
invasion and metastasis via β-catenin-mediated EMT and aerobic
glycolysis in colorectal cancer. Front Cell Dev Biol. 9:6601592021.
View Article : Google Scholar
|
42
|
Dai ZT, Xiang Y, Zhang XY, Zong QB, Wu QF,
Huang Y, Shen C, Li JP, Ponnambalam S and Liao XH: Regulation of
follistatin-like 3 expression by miR-486-5p modulates gastric
cancer cell proliferation, migration and tumor progression. Aging
(Albany NY). 13:20302–20318. 2021. View Article : Google Scholar
|
43
|
Wang J, Li D, Cang H and Guo B: Crosstalk
between cancer and immune cells: Role of tumor-associated
macrophages in the tumor microenvironment. Cancer Med. 8:4709–4721.
2019. View Article : Google Scholar : PubMed/NCBI
|
44
|
Duffy MJ, McKiernan E, O'Donovan N and
McGowan PM: Role of ADAMs in cancer formation and progression. Clin
Cancer Res. 15:1140–1144. 2009. View Article : Google Scholar : PubMed/NCBI
|
45
|
Carl-McGrath S, Lendeckel U, Ebert M,
Roessner A and Röcken C: The disintegrin-metalloproteinases ADAM9,
ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol.
26:17–24. 2005.
|
46
|
Wang H, Wu J and Guo W: SP1-Mediated
upregulation of lncRNA LINC01614 Functions a ceRNA for miR-383 to
facilitate glioma progression through regulation of ADAM12. Onco
Targets Ther. 13:4305–4318. 2020. View Article : Google Scholar : PubMed/NCBI
|
47
|
Yang C, Cao F, Huang S and Zheng Y:
Follistatin-like 3 correlates with lymph node metastasis and serves
as a biomarker of extracellular matrix remodeling in colorectal
cancer. Front Immunol. 12:7175052021. View Article : Google Scholar : PubMed/NCBI
|
48
|
Wang J, Zhang Z, Li R, Mao F, Sun W, Chen
J, Zhang H, Bartsch JW, Shu K and Lei T: ADAM12 induces EMT and
promotes cell migration, invasion and proliferation in pituitary
adenomas via EGFR/ERK signaling pathway. Biomed Pharmacother.
97:1066–1077. 2018. View Article : Google Scholar
|
49
|
Shapouri-Moghaddam A, Mohammadian S,
Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi
A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization,
and function in health and disease. J Cell Physiol. 233:6425–6440.
2018. View Article : Google Scholar : PubMed/NCBI
|
50
|
Weirather J, Hofmann UD, Beyersdorf N,
Ramos GC, Vogel B, Frey A, Ertl G, Kerkau T and Frantz S:
Foxp3+ CD4+ T cells improve healing after
myocardial infarction by modulating monocyte/macrophage
differentiation. Circ Res. 115:55–67. 2014. View Article : Google Scholar : PubMed/NCBI
|